Posted in | News | Chemistry | Electronics

Cree and Nippon Steel Sign Silicon Carbide Materials License Deal

Cree, semiconductor solutions provider for power and wireless applications, and Nippon Steel have signed silicon carbide (SiC) materials licensing contract.

As per the deal, Nippon Steel and its affiliates have received rights to produce and market SiC, a high-performance semiconductor material for use in electronic devices. Cree has also been offered rights to Nippon Steel’s patents related to SiC as part of the licensing agreement.

SiC is mainly used in the production of power, communication and lighting components that include RF power transistors, power switching devices and LEDs. Components made from SiC materials are employed in high-voltage power supplies, solar inverters and power conditioning.

Steve Kelley, CEO of Cree, stated that the company is an expert in SiC technologies that result in high brightness LEDs and energy-efficient power switching components. Cree is happy to partner with Nippon Steel for providing licensed SiC materials to the electronics device industry. The collaboration with Cree also supports Nippon Steel to reach its goal in the growing SiC market.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). Cree and Nippon Steel Sign Silicon Carbide Materials License Deal. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=28943.

  • MLA

    Chai, Cameron. "Cree and Nippon Steel Sign Silicon Carbide Materials License Deal". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=28943>.

  • Chicago

    Chai, Cameron. "Cree and Nippon Steel Sign Silicon Carbide Materials License Deal". AZoM. https://www.azom.com/news.aspx?newsID=28943. (accessed November 23, 2024).

  • Harvard

    Chai, Cameron. 2019. Cree and Nippon Steel Sign Silicon Carbide Materials License Deal. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=28943.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.